Complex regional pain syndrome and dysautonomia in a 14-year-old girl responsive to therapeutic plasma exchange

Journal of Clinical Apheresis

Volumn 31, Issue 4, 2016, Pages 368-374

  Hendrickson, Jeanne E ^a   Hendrickson, Emma T ^b   Gehrie, Eric A ^a   Sidhu, Davinder ^a   Wallukat, Gerd ^c,d   Schimke, Ingolf ^c   Tormey, Christopher A ^a,e  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Adams School   (United States)

^c Berlin Space Technologies GmbH   (Germany)

^d MAX DELBRÜCK CENTER FOR MOLECULAR MEDICINE   (Germany)

^e VA CONNECTICUT HEALTHCARE SYSTEM   (United States)

Author keywords

CRPS; immunosuppression; RSD; therapeutic plasma exchange

Indexed keywords

ALBUMIN; AMITRIPTYLINE; BETA 2 ADRENERGIC RECEPTOR AUTOANTIBODY; CAPSAICIN; CODEINE; DICLOFENAC; ERYTHROMYCIN; GABAPENTIN; GLUCONATE CALCIUM; IBUPROFEN; METOCLOPRAMIDE; MUSCARINIC M2 RECEPTOR AUTOANTIBODY; NAPROXEN; NICOTINIC ACETYLCHOLINE RECEPTOR AUTOANTIBODY; PARACETAMOL; PREDNISONE; PREGABALIN; PYRIDOSTIGMINE; RECEPTOR ANTIBODY; RITUXIMAB; TRAMADOL; UNCLASSIFIED DRUG;

ADOLESCENT; ANTIBODY BLOOD LEVEL; ANTIBODY DETECTION; APHERESIS DEVICE; ARTICLE; CARDIOVASCULAR SYMPTOM; CASE REPORT; CLINICAL FEATURE; COGNITIVE BEHAVIORAL THERAPY; COMPLEX REGIONAL PAIN SYNDROME; DESENSITIZATION; DIZZINESS; DYSAUTONOMIA; ELECTROCARDIOGRAM; FATIGUE; FEMALE; GASTROINTESTINAL MOTILITY DISORDER; GASTROINTESTINAL SYMPTOM; HUMAN; HYPOTENSION; IMMUNOSUPPRESSIVE TREATMENT; KNEE PAIN; LEG PAIN; MEDICAL HISTORY; NAUSEA; PHYSIOTHERAPY; PLASMAPHERESIS; POSTURAL ORTHOSTATIC TACHYCARDIA SYNDROME; REMISSION; SINUS TACHYCARDIA; SKIN BRUISING; STOMACH PARESIS; SUBSTITUTION THERAPY; SWEATING; THORAX PAIN; TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION; TREATMENT RESPONSE; VASOMOTOR DISORDER;

EID: 84978718671     PISSN: 07332459     EISSN: 10981101     Source Type: Journal    
DOI: 10.1002/jca.21407     Document Type: Article

References (49)

1. Harden RN, Oaklander AL, Burton AW, Perez RS, Richardson K, Swan M, Barthel J, Costa B, Graciosa JR, Bruehl S. Complex regional pain syndrome: practical diagnostic and treatment guidelines, 4th edition. Pain Med (Malden, Mass) 2013;14:180–229.
2. Schwartzman RJ. Systemic complications of complex regional pain syndrome. Neurosci Med 2012;3:225–242.
3. van de Beek WJ, van Hilten JJ, Roep BO. HLA-dq1 associated with reflex sympathetic dystrophy. Neurology 2000;55:457–458.
4. van Rooijen DE, Roelen DL, Verduijn W, Haasnoot GW, Huygen FJ, Perez RS, Claas FH, Marinus J, van Hilten JJ, van den Maagdenberg AM. Genetic HLA associations in complex regional pain syndrome with and without dystonia. J Pain 2012;13:784–789.
5. Blaes F, Schmitz K, Tschernatsch M, Kaps M, Krasenbrink I, Hempelmann G, Brau ME. Autoimmune etiology of complex regional pain syndrome (M. Sudeck). Neurology 2004;63:1734–1736.
6. Kohr D, Tschernatsch M, Schmitz K, Singh P, Kaps M, Schafer KH, Diener M, Mathies J, Matz O, Kummer W, Maihofner C, Fritz T, Birklein F, Blaes F. Autoantibodies in complex regional pain syndrome bind to a differentiation-dependent neuronal surface autoantigen. Pain 2009;143:246–251.
7. Kohr D, Singh P, Tschernatsch M, Kaps M, Pouokam E, Diener M, Kummer W, Birklein F, Vincent A, Goebel A, Wallukat G, Blaes F. Autoimmunity against the beta2 adrenergic receptor and muscarinic-2 receptor in complex regional pain syndrome. Pain 2011;152:2690–2700.
8. Dubuis E, Thompson V, Leite MI, Blaes F, Maihofner C, Greensmith D, Vincent A, Shenker N, Kuttikat A, Leuwer M, Goebel A. Longstanding complex regional pain syndrome is associated with activating autoantibodies against alpha-1a adrenoceptors. Pain 2014;155:2408–2417.
9. Goebel A, Leite MI, Yang L, Deacon R, Cendan CM, Fox-Lewis A, Vincent A. The passive transfer of immunoglobulin G serum antibodies from patients with longstanding complex regional pain Syndrome. Eur J Pain 2011;15:504.e501–506.
10. Tekus V, Hajna Z, Borbely E, Markovics A, Bagoly T, Szolcsanyi J, Thompson V, Kemeny A, Helyes Z, Goebel A. A CRPS-IgG-transfer-trauma model reproducing inflammatory and positive sensory signs associated with complex regional pain syndrome. Pain 2014;155:299–308.
11. van de Vusse AC, Stomp-van den Berg SG, Kessels AH, Weber WE. Randomised controlled trial of gabapentin in complex regional pain syndrome type 1 [isrctn84121379]. BMC Neurol 2004;4:13.
12. Varenna M, Adami S, Rossini M, Gatti D, Idolazzi L, Zucchi F, Malavolta N, Sinigaglia L. Treatment of complex regional pain syndrome type I with neridronate: a randomized, double-blind, placebo-controlled study. Rheumatology (Oxford) 2013;52:534–542.
13. Varenna M, Adami S, Sinigaglia L. Bisphosphonates in complex regional pain syndrome type I: how do they work? Clin Exp Rheumatol 2014;32:451–454.
14. Braus DF, Krauss JK, Strobel J. The shoulder-hand syndrome after stroke: a prospective clinical trial. Ann Neurol 1994;36:728–733.
15. Christensen K, Jensen EM, Noer I. The reflex dystrophy syndrome response to treatment with systemic corticosteroids. Acta Chir Scand 1982;148:653–655.
16. Atalay NS, Ercidogan O, Akkaya N, Sahin F. Prednisolone in complex regional pain syndrome. Pain Physician 2014;17:179–185.
17. Eisenberg E, Sandler I, Treister R, Suzan E, Haddad M. Anti tumor necrosis factor - alpha adalimumab for complex regional pain syndrome type 1 (CRPS-I): a case series. Pain Pract 2013;13:649–656.
18. Huygen FJ, Niehof S, Zijlstra FJ, van Hagen PM, van Daele PL. Successful treatment of CRPS 1 with anti-TNF. J Pain Symptom Manage 2004;27:101–103.
19. Goebel A, Netal S, Schedel R, Sprotte G. Human pooled immunoglobulin in the treatment of chronic pain syndromes. Pain Med (Malden, Mass) 2002;3:119–127.
20. Goebel A, Stock M, Deacon R, Sprotte G, Vincent A. Intravenous immunoglobulin response and evidence for pathogenic antibodies in a case of complex regional pain syndrome 1. Ann Neurol 2005;57:463–464.
21. Medlin F, Zekeridou A, Renaud S, Kuntzer T. Favorable outcome of an acute complex regional pain syndrome with immunoglobulin infusions. Clin J Pain 2013;29:e33–e34.
22. Goebel A, Baranowski A, Maurer K, Ghiai A, McCabe C, Ambler G. Intravenous immunoglobulin treatment of the complex regional pain syndrome: a randomized trial. Ann Intern Med 2010;152:152–158.
23. Goebel A, Shenker N, Padfield N, Shoukrey K, McCabe C, Serpell M, Sanders M, Murphy C, Ejibe A, Milligan H, Kelly J, Ambler G. Low-dose intravenous immunoglobulin treatment for complex regional pain syndrome (LIPS): study protocol for a randomized controlled trial. Trials 2014;15:404.
24. Schwartz J, Winters JL, Padmanabhan A, Balogun RA, Delaney M, Linenberger ML, Szczepiorkowski ZM, Williams ME, Wu Y, Shaz BH. Guidelines on the use of therapeutic apheresis in clinical practice-evidence-based approach from the writing committee of the American society for apheresis: the sixth special issue. J Clin Apheresis 2013;28:145–284.
25. Blaes F, Dharmalingam B, Tschernatsch M, Feustel A, Fritz T, Kohr D, Singh P, Kaps M, Szalay G. Improvement of complex regional pain syndrome after plasmapheresis. Eur J Pain (Lond Engl) 2015;19:503–507.
26. Goebel A, Jones S, Oomman S, Callaghan T, Sprotte G. Treatment of long-standing complex regional pain syndrome with therapeutic plasma exchange: a preliminary case series of patients treated in 2008-2014. Pain Med (Malden, Mass) 2014;15:2163–2164.
27. Hjermstad MJ, Fayers PM, Haugen DF, Caraceni A, Hanks GW, Loge JH, Fainsinger R, Aass N, Kaasa S. Studies comparing numerical rating scales, verbal rating scales, and visual analogue scales for assessment of pain intensity in adults: a systematic literature review. J Pain Symptom Manage 2011;41:1073–1093.
28. Wallukat G, Munoz Saravia SG, Haberland A, Bartel S, Araujo R, Valda G, Duchen D, Diaz Ramirez I, Borges AC, Schimke I. Distinct patterns of autoantibodies against G-protein-coupled receptors in chagas' cardiomyopathy and megacolon. Their potential impact for early risk assessment in asymptomatic chagas' patients. J Am Coll Cardiol 2010;55:463–468.
29. Strunecka A, Krpejsova L, Palecek J, Macha J, Maturova M, Rosa L, Paleckova A. Transbilayer redistribution of phosphatidylserine in erythrocytes of a patient with autoerythrocyte sensitization syndrome (psychogenic purpura). Folia Haematol Int Mag Klin Morphol Blutforsch 1990;117:829–841.
30. Edinger LK, Schwartzman RJ. Gardner-diamond syndrome associated with complex regional pain syndrome. J Dermatol Case Rep 2013;7:10–14.
31. Alexander GM, Peterlin BL, Perreault MJ, Grothusen JR, Schwartzman RJ. Changes in plasma cytokines and their soluble receptors in complex regional pain syndrome. J Pain 2012;13:10–20.
32. Lenz M, Uceyler N, Frettloh J, Hoffken O, Krumova EK, Lissek S, Reinersmann A, Sommer C, Stude P, Waaga-Gasser AM, Tegenthoff M, Maier C. Local cytokine changes in complex regional pain syndrome type I (CRPS I) resolve after 6 months. Pain 2013;154:2142–2149.
33. Schlereth T, Drummond PD, Birklein F. Inflammation in CRPS: role of the sympathetic supply. Auton Neurosci 2014;182:102–107.
34. Wallukat G, Schimke I. Agonistic autoantibodies directed against G-protein-coupled receptors and their relationship to cardiovascular diseases. Semin Immunopathol 2014;36:351–363.
35. Smith JA, Karalis DG, Rosso AL, Grothusen JR, Hessen SE, Schwartzman RJ. Syncope in complex regional pain syndrome. Clin Cardiol 2011;34:222–225.
36. Li H, Yu X, Liles C, Khan M, Vanderlinde-Wood M, Galloway A, Zillner C, Benbrook A, Reim S, Collier D, Hill MA, Raj SR, Okamoto LE, Cunningham MW, Aston CE, Kem DC. Autoimmune basis for postural tachycardia syndrome. J Am Heart Assoc 2014;3:e000755
37. Vernino S, Low PA, Fealey RD, Stewart JD, Farrugia G, Lennon VA. Autoantibodies to ganglionic acetylcholine receptors in autoimmune autonomic neuropathies. New Engl J Med 2000;343:847–855.
38. Thieben MJ, Sandroni P, Sletten DM, Benrud-Larson LM, Fealey RD, Vernino S, Lennon VA, Shen WK, Low PA. Postural orthostatic tachycardia syndrome: the mayo clinic experience. Mayo Clin Proc 2007;82:308–313.
39. Pasha SF, Lunsford TN, Lennon VA. Autoimmune gastrointestinal dysmotility treated successfully with pyridostigmine. Gastroenterology 2006;131:1592–1596.
40. Vernino S, Hopkins S, Wang Z. Autonomic ganglia, acetylcholine receptor antibodies, and autoimmune ganglionopathy. Auton Neurosci 2009;146:3–7.
41. Dhamija R, Tan KM, Pittock SJ, Foxx-Orenstein A, Benarroch E, Lennon VA. Serologic profiles aiding the diagnosis of autoimmune gastrointestinal dysmotility. Clin Gastroenterol 2008;6:988–992.
42. Imrich R, Vernino S, Eldadah BA, Holmes C, Goldstein DS. Autoimmune autonomic ganglionopathy: treatment by plasma exchanges and rituximab. Clin Auton Res 2009;19:259–262.
43. Vernino S, Lindstrom J, Hopkins S, Wang Z, Low PA. Characterization of ganglionic acetylcholine receptor autoantibodies. J Neuroimmunol 2008;197:63–69.
44. McKeon A, Lennon VA, Lachance DH, Fealey RD, Pittock SJ. Ganglionic acetylcholine receptor autoantibody: oncological, neurological, and serological accompaniments. Arch Neurol 2009;66:735–741.
45. Hollenbeck R, Black BK, Peltier AC, Biaggioni I, Robertson D, Winton EF, Raj SR. Long-term treatment with rituximab of autoimmune autonomic ganglionopathy in a patient with lymphoma. Arch Neurol 2011;68:372–375.
46. Tambralli A, Beukelman T, Cron RQ, Stoll ML. Safety and efficacy of rituximab in childhood-onset systemic lupus erythematosus and other rheumatic diseases. J Rheumatol 2015;42:541–546.
47. El-Hallak M, Binstadt BA, Leichtner AM, Bennett CM, Neufeld EJ, Fuhlbrigge RC, Zurakowski D, Sundel RP. Clinical effects and safety of rituximab for treatment of refractory pediatric autoimmune diseases. J Pediatr 2007;150:376–382.
48. Iorio R, Damato V, Alboini PE, Evoli A. Efficacy and safety of rituximab for myasthenia gravis: a systematic review and meta-analysis. J Neurol, Oct 4 2012 (epub ahead of print), PMID: 25308632.
49. Lebrun C, Bourg V, Tieulie N, Thomas P. Successful treatment of refractory generalized myasthenia gravis with rituximab. Eur J Neurol 2009;16:246–250.